Chemistry Wealth Management’s Enterprise Products Partners EPD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$230K Hold
6,257
0.04% 194
2026
Q1
$237K Sell
6,257
-1,577
-20% -$55.8K 0.04% 187
2025
Q4
$251K Hold
7,834
0.05% 173
2025
Q3
$245K Sell
7,834
-3,315
-30% -$105K 0.05% 180
2025
Q2
$346K Buy
11,149
+963
+9% +$30K 0.07% 133
2025
Q1
$348K Sell
10,186
-295
-3% -$9.82K 0.08% 124
2024
Q4
$329K Buy
10,481
+117
+1% +$3.59K 0.08% 132
2024
Q3
$302K Buy
+10,364
New +$303K 0.07% 135

Other funds holding EPD

Chemistry Wealth Management's EPD Position: Q2 2026 in Review

Chemistry Wealth Management held its Enterprise Products Partners (EPD) position steady in Q2 2026 at 6,257 shares worth $230K. The position accounts for 0.04% of the portfolio, ranked #194.

Chemistry Wealth Management first reported a position in EPD in Q3 2024 and has held it in 8 quarters since. The position peaked at $348K in Q1 2025. 817 funds tracked by Wall St. Rank hold EPD as of Q2 2026.

  • Chemistry Wealth Management held 6,257 shares of Enterprise Products Partners worth $230K as of Q2 2026.
  • Chemistry Wealth Management left its Enterprise Products Partners share count unchanged in Q2 2026.
  • Enterprise Products Partners made up 0.04% of Chemistry Wealth Management's portfolio in Q2 2026, its #194 holding.
  • Chemistry Wealth Management first reported a position in Enterprise Products Partners in Q3 2024 and has held it in 8 quarters since.
  • Chemistry Wealth Management's Enterprise Products Partners position peaked at $348K in Q1 2025.
  • 817 funds tracked by Wall St. Rank held Enterprise Products Partners as of Q2 2026.

Based on Chemistry Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.